Genomic organization, promoter analysis, and chromosomal localization of the gene for the mouse glial high-affinity glutamate transporter Slc1a3

被引:37
作者
Hagiwara, T
Tanaka, K
Takai, S
MaenoHikichi, Y
Mukainaka, Y
Wada, K
机构
[1] NATL INST NEUROSCI, DEPT DEGENERAT NEUROL DIS, NCNP, KODAIRA, TOKYO 187, JAPAN
[2] INT MED CTR JAPAN, RES INST, DEPT GENET, SHINJUKU KU, TOKYO 162, JAPAN
基金
日本科学技术振兴机构;
关键词
D O I
10.1006/geno.1996.0226
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The mouse gene encoding glial high-affinity, Na+-dependent glutamate transporter Slc1a3 (GluT-1/GLAST) was isolated, and its structural organization was characterized. The gene appeared to exist as a single copy in the mouse genome and comprised 10 exons spanning more than 56 kilobases. The transcription initiation sites were mapped to positions 503, which is the first transcriptional point (defined as +1), 128 (+376), and 64 (+440) basepairs upstream of the 3'-end of exon 1 by primer extension. The 5'-flanking region of the mouse GluT-1 gene had a typical CCAAT box and a GC box but lacked a TATA box. These features of the promoter region were characteristic of housekeeping genes. The fusion plasmids containing approximately 4 kb of the 5'-flanking region (-3830 to +450) and the firefly luciferase gene induced a significant luciferase activity when transfected into COS-1 cells. Distal deletion of the 5'-flanking region, leaving 619 bp (-169 to +450), resulted in a marked decrease in luciferase activity in COS-1 cells, suggesting that a CCAAT box, which was positioned at -200, is necessary for the expression of this gene. In situ hybridization localized this gene to mouse chromosome 15A2. These structural features will lead to a better understanding of the regulatory mechanism of the expression of the GluT-1 gene by ischemia and will also provide a basis for future evolutionary comparisons with other neurotransmitter transporters. (C) 1996 Academic Press, Inc.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 40 条
  • [1] ARRIZA JL, 1994, J NEUROSCI, V14, P5559
  • [2] Attwell David, 1994, Current Opinion in Neurobiology, V4, P353, DOI 10.1016/0959-4388(94)90096-5
  • [3] MECHANISMS OF EXCITOTOXICITY IN NEUROLOGIC DISEASES
    BEAL, MF
    [J]. FASEB JOURNAL, 1992, 6 (15) : 3338 - 3344
  • [4] BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
  • [5] GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM
    CHOI, DW
    [J]. NEURON, 1988, 1 (08) : 623 - 634
  • [6] HUMAN AND MOUSE DOPAMINE TRANSPORTER GENES - CONSERVATION OF 5'-FLANKING SEQUENCE ELEMENTS AND GENE STRUCTURES
    DONOVAN, DM
    VANDENBERGH, DJ
    PERRY, MP
    BIRD, GS
    INGERSOLL, R
    NANTHAKUMAR, E
    UHL, GR
    [J]. MOLECULAR BRAIN RESEARCH, 1995, 30 (02): : 327 - 335
  • [7] HOW BIG IS THE UNIVERSE OF EXONS
    DORIT, RL
    SCHOENBACH, L
    GILBERT, W
    [J]. SCIENCE, 1990, 250 (4986) : 1377 - 1382
  • [8] COMPILATION OF VERTEBRATE-ENCODED TRANSCRIPTION FACTORS
    FAISST, S
    MEYER, S
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (01) : 3 - 26
  • [9] A NEW FAMILY OF NEUROTRANSMITTER TRANSPORTERS - THE HIGH-AFFINITY GLUTAMATE TRANSPORTERS
    KANAI, Y
    SMITH, CP
    HEDIGER, MA
    [J]. FASEB JOURNAL, 1993, 7 (15) : 1450 - 1459
  • [10] PRIMARY STRUCTURE AND FUNCTIONAL-CHARACTERIZATION OF A HIGH-AFFINITY GLUTAMATE TRANSPORTER
    KANAI, Y
    HEDIGER, MA
    [J]. NATURE, 1992, 360 (6403) : 467 - 471